Long-course venetoclax with hypomethylating agents in unfit AML patients shows stable efficacy and MRD prognostic value
Frail Leukemia Patients See Better Results With New Blood Monitoring
This single-center retrospective analysis evaluated long-course venetoclax combined with hypomethylating agents in unfit AML patients.
A new look at blood tests shows how well frail leukemia patients respond to standard treatment.
Review of survey data highlights high rates of misdiagnosis and delayed diagnosis in metastatic invasive lobular breast cancer
One in Four Metastatic Breast Cancer Patients Misdiagnosed at First Visit
This cross-sectional survey review analyzed patient-reported data from 525 individuals with invasive lobular breast cancer (ILC).
One in four metastatic breast cancer patients were misdiagnosed at their first doctor visit, delaying care for a stealthy cancer that spread…
FDA Approves Itovebi (Itovebi) for Endocrine-Resistant, PIK3CA-Mutated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
FDA approves new breast cancer drug Itovebi for a specific type of advanced cancer
The FDA approved Itovebi in combination with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, HR-positive, H…
A new oral drug, Itovebi, is now FDA-approved for advanced breast cancer with a specific genetic mutation, offering another option when horm…
Relacorilant plus nab-paclitaxel improves overall survival in platinum-resistant ovarian cancer
New Drug Combo Extends Survival for Tough Ovarian Cancer Cases
In a phase 3 randomised controlled trial of 381 patients with platinum-resistant ovarian cancer, relacorilant plus nab-paclitaxel significan…
This combination offers a new, simpler option for patients who have run out of standard treatments.
Savolitinib and durvalumab combination yields response rates of 34% to 53% in papillary renal cancer patients
New Hope for a Tough Kidney Cancer Type
This single-arm phase II study evaluated savolitinib and durvalumab in 41 treatment-naïve or pretreated patients with papillary renal cancer…
A new drug pair breaks the shield blocking treatment for a rare kidney cancer type, offering patients a chance at longer survival after stan…
Gedatolisib plus fulvestrant with or without palbociclib improved progression-free survival versus fulvestrant monotherapy in advanced breast cancer
New Drug Combo Slashes Breast Cancer Progression Risk by 75%
This phase III randomized trial evaluated gedatolisib plus fulvestrant with or without palbociclib in patients with hormone receptor-positiv…
For patients with tough-to-treat advanced breast cancer, a new three-drug combination nearly quadrupled the time before the cancer started g…
Retrospective cohort of 443 glioma patients analyzed under successive WHO classifications from 2007 to 2021
Study reviews glioma diagnosis changes with updated WHO classification criteria
This retrospective analysis of a cohort from a high-volume Latin American center evaluated 443 patients undergoing elective tumor surgery be…
New WHO rules mean nearly a quarter of brain tumors in Latin America are now labeled 'not otherwise specified' due to limited molecular test…
Neoadjuvant atezolizumab shows spatial biomarker changes in operable urothelial carcinoma patients
How a Bladder Cancer Drug Remodels the Tumor Neighborhood
This single-arm, phase II trial evaluated neoadjuvant atezolizumab in patients with operable urothelial carcinoma.
A bladder cancer drug physically breaks down the walls blocking immune cells in tumors, helping doctors predict which patients will respond …
Bayesian network meta-analysis of exercise interventions for depression and anxiety in cancer survivors
Mind-Body Exercises Top New Depression and Anxiety Relief List
This Bayesian network meta-analysis evaluated different exercise interventions versus non-exercise controls for depression and anxiety in 7,…
Slow, gentle movement like Tai Chi and Pilates now ranks highest for easing depression and anxiety in cancer survivors, offering a practical…
Narrative review examines multimodal AI for glioma using neuroimaging and hematologic biomarkers
AI May Help Doctors Spot Brain Tumors Without Surgery
This narrative review explores the potential of multimodal artificial intelligence (AI) integrating neuroimaging and hematologic biomarkers …
This approach could make brain tumor diagnosis and monitoring less invasive and more precise.
Meta-analysis shows local consolidative therapy plus systemic therapy improves survival in driver-negative oligometastatic NSCLC
For a specific lung cancer group, adding local treatment to standard drugs significantly improved survival time
This systematic review and meta-analysis evaluated local consolidative therapy combined with systemic therapy versus systemic therapy alone …
Adding local treatment to standard drugs significantly improved survival time for a specific lung cancer group with spread to only a few pla…
Adjunctive Chinese herbal medicine associated with symptom improvement in 83 breast cancer patients receiving Western medicine
Herbs May Ease Breast Cancer Symptoms
This prospective observational study evaluated 83 patients with breast cancer receiving Western medicine alongside adjunctive scientific Chi…
Women using Chinese herbs alongside breast cancer treatment reported less fatigue, fewer hot flashes, and less pain compared to those taking…